share_log
Reuters ·  May 2 08:30
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment